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Abstract 
In poultry production Escherichia coli autogenous vaccines are often used. However, the efficacy of 
autogenous E. coli vaccinations has not been evaluated experimentally in chickens after start of lay. 
The aim of the present study was to evaluate the protective effect of an autogenous E. coli vaccine 
in  broiler breeders. Three groups of 28 weeks old broiler breeders (unvaccinated, vaccinated once 
and twice, respectively) were challenged with a homologous E. coli strain (same strain as included 
in the vaccine) or a heterologous challenge strain in an experimental ascending model. The clinical 
outcome was most pronounced in the unvaccinated group; however, the vast majority of chickens in 
the vaccinated groups had severe pathological manifestations similar to findings in the unvaccinated 
group after challenge with a homologous as well as a heterologous E. coli strain. Although 
significant titer rises in IgY antibodies were observed in the twice vaccinated group, antibodies did 
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not confer significant protection in terms of pathological impact. Neither could transfer of maternal 
derived antibodies to offspring be demonstrated. 
In conclusion, with the use of the present model for ascending infection, significant protection of an 
autogenous E. coli vaccine against neither a homologous nor a heterologous E. coli challenge could 
not be documented. 
 
Keywords: APEC, Vaccine, autogenous, challenge study,  broiler breeders 
Introduction 
Avian pathogenic E. coli (APEC) is one of the most important opportunist pathogens in 
industrialized poultry production. APEC is associated with a variety of extraintestinal disease 
syndromes. In young chicks, APEC-induced omphalitis/yolk sac infection may result in generalized 
septicaemia with perihepatitis, whereas respiratory infection may occur after aerogenic transmission 
(Antao et al., 2008; Pires dos Santos et al., 2013).  In adult, egg-laying birds, peritonitis and 
salpingitis are among the most common manifestations of APEC infections, and assumed to occur 
by ascending bacteria entering the reproductive tract as faecal contaminants through the cloaca 
(Jordan et al., 2005; Landman and Cornelissen 2006; Pires dos Santos et al., 2013). 
Due to the increased concern for antibiotic resistant bacteria, including e.g. extended spectrum beta-
lactamase (ESBL) producing E. coli ( 2014), and animal welfare issues, prophylaxis is favoured 
over antibiotic treatment of E. coli infections. It has previously been assumed that disease due to E. 
coli is a result of either management deficiencies, e.g. an inappropriate biosecurity level and 
insufficient egg hygiene or decreased immunocompentency of the birds due to concurrent infectious 
diseases, such as infectious bronchitis or adenovirus (Koncicki et al., 2012; Matthijs et al., 2003; 
Peighambari et al., 2002).  Currently, accumulating evidence has led to the acceptance that certain 
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clones of E. coli may act as primary pathogens and cause severe disease and high mortality despite 
of high standard management, low stress levels and the absence of concurrent diseases (Bisgaard et 
al., 2010; Dziva et al., 2013; Gregersen et al., 2010; Pires dos Santos et al., 2013). In such cases, 
control of E. coli infections relies on efficient vaccination strategies. The licensed vaccine, 
Poulvac® is indicated for protection in young birds (broilers or chicks to become broiler breeders or 
layers) against septicaemia, peritonitis and perihepatitis, and has proven effective in several 
experimental evaluations (Fernandes et al., 2013; Mombarg et al., 2014; Sadeyen et al., 2015b).  For 
Poulvac®, the therapeutic indications do not include long-term protection beyond the 5-6 weeks of 
the life of broilers. Field observations concerning E. coli mortality in Poulvac® 
vaccinated/unvaccinated broiler breeders after start of lay (personal communication, poultry field 
veterinarian), has called for further vaccine-based long-term protection of broiler breeders. 
Consequently, autogenous vaccines are frequently used in broiler breeder flocks, despite 
documentation on the efficacy of such vaccines in terms of ascending E. coli infections is lacking. 
Therefore, the aim of this study was to investigate the additive protective effect of an autogenous E. 
coli vaccine in broiler breeders pre-vaccinated with a licensed E. coli vaccine (Poulvac®). The 
purpose was to assess the level of protection against a homologous and a heterologous E. coli strain 
following experimental infection. In addition, transfer of maternal derived antibodies (MAD) was 
assessed by comparing MAD levels in offspring of vaccinated breeders with offspring of 
unvaccinated parents. 
Material and Methods 
Experimental groups and housing 
Sixty broiler breeders (genetic line Ross 308) were purchased from a commercial breeder, where 
they were housed until 27 weeks of age.  As day-old and at 12 week of age, all broiler breeders had 
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been vaccinated with a licensed, live, attenuated E. coli vaccine (Poulvac© E. coli), in which all 
birds of all groups had been vaccinated with a coarse spray of Poulvac® according to the 
manufacturer´s instructions. At 28 weeks of age birds were subsequently divided into three 
experimental groups of 20 chickens per group. Chickens in group one did not receive further E. coli 
vaccines. Chickens in group two were at 18 weeks of age vaccinated subcutaneously with a 
formalin inactivated, mineral-oil adjuvant E. coli vaccine containing three isolates of E. coli (an E. 
coli isolate  S117, serotype O78:H4  (E. coli E44), obtained from the liver of a diseased broiler 
breeder in 2015 (Ronco et al., 2016), another isolate of E. coli ST117 ( serotype unknown) obtained 
from a cellulitis lesion in a broiler in 2015 and finally, an isolate of E. coli ST140, serotype O2:H5 
(E. coli E51), obtained in 2015 from the liver of broilers suffering from septicaemia (Ronco et al., 
2016).  Chickens in group three received the autogenous vaccine twice, namely at 14 and 18 weeks 
of age.  
At 27 weeks of age all birds of the three groups were transferred to the experimental housing unit at 
University of Copenhagen. They were allowed one week of acclimatisation before the experimental 
infections. During the acclimatisation week the birds were monitored for wellbeing, normal avian 
behaviour and appetite. Birds were kept free range on deep litter in separate floor pens (2.4 × 2.4 m) 
with unlimited access to nests, perches and dust baths. Water was provided ad libitum in all groups 
throughout the experiment. The birds were kept on restricted diet according to age and egg 
production (170 g/hen/day). All procedures performed on the birds were approved and licensed by 
the Danish Animal Experiments Inspectorate (license no. 2013-15-2934-00923).  
Preparation of inocula 
All strains were stored at - 80°C in Brain and Heart Infusion (BHI) broth (Oxoid, Basingstoke, UK) 
in 15% (v/v) glycerol until needed. The day before inoculation all strains were grown overnight in 
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BHI broth. The inoculum for each strain was diluted to 5×106 CFU, and 0.1 ml of the diluted 
inocula were aspirated in 1ml syringes and kept on ice until infection. 
Oviduct infections and post mortem assessment 
The study setup was designed to mimic field conditions. The birds were divided into three groups, 
each containing 20 birds. Within each group, two subgroups, A and B, were established (Table 1). 
For each group, subgroup A consisted of birds 1-10 and were infected with the vaccine strain  E. 
coli E44, while birds in subgroup B ( birds 11-20) were infected with E. coli SCI_07 (serotype O 
non-typable:H31). The latter strain is a Brazilian isolate obtained from periorbital skin of a chicken 
suffering from "swollen head" syndrome (Rojas et al., 2012), and assumed to represent 
heterologous E. coli strain. The experiments were performed as described by Pors et al.( 2014). 
Briefly, each hen underwent laparotomy under general anaesthesia and received a dose of 0.1ml of 
approximately 5×106 CFU injected into the salpinx. To avoid post-surgical pain a semisynthetic 
opioid, buprenorphine (0.3 mg/kg), was administered to all hens in all experimental groups. 
Additional buprenorphine treatments was administered individually if signs of discomfort and due 
the infection (ruffled feathers, clumping together, reduced appetite and activity), if these signs 
persisted for more than 12 hours despite treatment or if the symptoms were severe the birds were 
euthanized for welfare reasons, according to the predefined humane end points in the licence 
approved by the animal expectorate. Unless indicated by clinical symptoms and significant 
abnormal behaviour, all chickens were euthanized seven days post infection (d.p.i.) and directly 
submitted to post mortem analysis , where lesions were scored according to the scorings system 
outlined by Pors et al. ( 2014). Briefly, each organsystem (ovary, peritoneum and salpinx) was 
evaluated based pre-defined criteria and assigned a score between 0 (no macroscopically pathology) 
and 4 for each criteria assessed. The total cumulative score is the sum of scores for all evaluated 
organsystems in addition to scores on spleen proliferation and lymphatic reaction. Two pathologists 
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scored all lesions of all chickens during the post mortem examination, and if any incongruence in 
scoring occurred, a third pathologist also participated in the scoring process.   
Bacteriological swabs were sampled from liver, bone marrow and salpinx and plated directly on 
agar plates (Oxoid, Basingstoke, UK) with 5% bovine blood. Re-isolation was considered positive 
if abundant growth in pure culture of E. coli was obtained.Serology 
The antigen response following challenge with E. coli E4 and SCI_07, respectively, were 
determined by Enzyme-Linked Immunosorbent Assay (ELISA). For all birds, blood samples of 5 
ml full blood were obtained at the day of challenge and the day of euthanasia (seven days post 
challenge, except group 1A, which was euthanized 48 h post challenge). The samples were then 
centrifuged at 4000×g for 10 min. The plasma fraction was transferred to separate tubes and kept at 
-20 °C until they were processed for ELISA measurement of antibody content. For ELISA,  Nunc-
Immuno™ MicroWell™ 96-Well Plates (Thermo Scientific, Waltham, MA, USA) were coated 
overnight at 4 °C with 0.5 μg whole cell sonicates of E. coli E4 and SCI_07, respectively. The 
sonicates were diluted in carbonate-bicarbonate buffer (pH 9.6) (Sigma-Aldrich, St. Louis, MO, 
USA) to obtain a concentration of 5 mg/ml antigen protein. Each well was then washed; this and all 
subsequent washing steps consisted of three washes in 350 μL washing buffer (PBS + 0.05% Tween 
20). The wells were blocked for 2 h at room temperature in 200 μL blocking solution (PBS 
containing 0.05% Tween 20 and 2% bovine serum albumin (BSA) and washed. Serum samples 
from five birds were pooled, and the antibody titers were assayed by serial 3-fold dilutions of serum 
ranging from 1:300 to 1:24300. All dilutions were prepared in triplicate in dilution buffer (PBS 
containing 0.05% Tween 20 and 0.1% BSA), 100 μL were added to each well and plates were 
incubated for 1 h at 37 °C. For each assay, 12 control wells were included, which contained pure 
dilution buffer; in 6 of these wells a secondary antibody was added as a measure of background, and 
the other 6 wells remained blank as a negative control for the ELISA. Following incubation, the 
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wells were washed and 100 μL polyclonal goat anti-chicken IgG (Fc):HRP (AbD Serotec, 
Puchheim, Germany), diluted 1:4000 in diluting buffer, were added to each well and the plates 
incubated for a further 1 h at 37 °C and then washed. To detect the binding, 100 μL of 3,3′,5,5′-
tetramethylbenzidine (TMB) liquid substrate (Sigma) were added to each well. The plates were 
incubated for 2 min and then the reaction was stopped by addition of 100 μL 1 M HCl. The 
absorbance was read immediately at 450 nm in a PowerWave XS spectrophotometer (BioTek 
Instruments, Winooski, VT, USA). 
The antibody titres were calculated for the measured absorbance at 450 nm (Villumsen and Raida 
2013), using the “Antibody Titers” online data analysis tool “Myassay” ( 2016).  
Assessment of maternal derived antibodies in the offspring of autogenously vaccinated and non- 
vaccinated broiler breeders, respectively, was done as described above, except SCI_07 was  
replaced by a sonicate from an isolate of the second E. coli included vaccine (E. coli E51) to verify 
if any or both of the vaccine strains generated detectable MADs. 
Statistical analysis 
For the pathology assessment, Kruskal–Wallis followed by Dunn’s Multiple Comparison test was 
used for comparisons of lesion scores. For detection of differences in lesion scores between 
challenge strains within the same group (1x autovaccinated), the Mann-Whitney t-test was used for 
comparing median scores. For serology, two-way ANOVA was used to analyse for statistical 
significant rise in antibodies in vaccinated groups (2A, 2B, 3A and 3B) compared to the level of 
antibodies before and after challenge in the control groups (group 1A and 1B). Subsequently, 
Turkey's multiple comparison test was performed to evaluate if the level of antibodies before and 
after challenge differed significantly within each challenge group. 
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Seven days survival rate was compared between the six groups using chi-square tests. 
 All the statistical analysis was done with Graphpad Prism (Graphpad Software, Inc., La Jolla, 
USA). P-values <0.05 were considered statistically significant. 
 
Results 
Experimental infections 
Overall, group 1A ( not autogenously vaccinated, challenged with vaccine strain E44) was the only 
group that had a significantly different survival rate (lower) compared to any of the other groups ( 
P<0.001) (Table 1).  Besides mortality, the design of the study included pathology (lesions score) as 
the main criteria to evaluate the possible protective effect of an autogenous vaccine, while the 
clinical appearance of the birds at the time from challenge to euthanization was not standardized  to 
be included as criteria for assessment for vaccine efficiency. Nevertheless, based on the animal 
experiments legislation compulsory, routinely daily monitoring and registration of the wellbeing of 
the birds, significant differences/changes in the clinical appearance between groups after challenge 
was observed. The monitoring was carried out at least three times each day; in the morning and 
afternoon (feeding times) by certified and trained animal caretakers and in the evening the birds 
were attended by a veterinarian.  Initially, no clinical sign were observed in group 3A and 3B, they 
had normal appetite (all birds were alert during feeding and all feed was eaten) after challenge, they 
moved around freely in their pens and generally showed normal avian behaviour, including dust-
bathing and escape reaction when their pen was entered by a caretaker/veterinarian. However, at 
day 5-6 post infection, both groups had a decrease in clinical performance and showed signs of 
being depressed, similar to the signs observed for group 2A and 2B (see below).  
 
 
9 
 
The clinical performance for group 2A and 2B indicated that these groups were more severely 
affected. More birds had ruffled feathers, tended to squeeze into the corners of the pen and some 
lacked interest in feed.  
The clinical appearance of group 1B was similar to the birds in group 2B. For group 1A, three birds 
died within 24 hour post challenge, while the rest was very severely affected. All birds were 
anorexic; little or no interest in the surroundings; they had abdominal respiration with beaks open, 
and tended to group together in the pen. Also, they exhibited weakened escape reaction. For welfare 
reasons the remaining seven birds were euthanized two days post challenge in line with the 
predefined humane endpoints. 
 Overall, at post mortem examination varying degrees of peritonitis, salpingitis and oophoritis was 
found. For the vast majority of all birds irrespective of group, gross macroscopic lesions were 
observed, but within groups large variation was demonstrated (Fig. 1).  The birds of group 1A had 
the highest median pathological scores for total lesion, ovary and salpinx (Table 3, Fig. 1). 
However, scoring of this group was biased as time of challenge was only two days versus seven 
days for the remaining groups. None of median cumulative scores of lesions differed significantly 
between groups (P<0.100), which partly may be explained by the large within-group variation (Fig. 
1).   
Development of severe diffuse effusive/exudative peritonitis, where the peritoneal membranes had 
an opaque and thickened appearance, was evident for all groups and peritoneum lesion scores did 
not differ between groups (P= 0.594).  Large amounts of fibrinopurulent exudates were present 
around all organs and spread all over the abdominal cavity.  
Inspection of the reproductive organs, ovary and salpinx (Fig. 1C+D) demonstrated that  infection 
of the salpinx was very limited in approximately half of the birds in group 2, regardless of the 
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challenge strain, corresponding to the lack of E. coli re-isolation from these birds (Table 2). Overall 
the most severe changes in pathology of the salpinx was observed in group 1A, in which the 
pathology score were significantly higher than the other groups (Fig. 1D) . For both strains the 
lesions present in the ovaries of all the bird were light to moderate circulatory changes including 
congestion of blood vessels, multifocal to diffuse dispersion of pus around and within the follicles, 
and several degenerative and/or regressive follicles. Regarding the oviduct intraluminal presence of 
purulent exudate ranged from single flakes to diffuse distribution throughout the salpinx. In the 
mucosal membranes of the salpinx, tissue circulatory changes like oedema, hyperaemia or pale 
mucosa could be observed within each group. No significant difference in lesion scores of the 
overies was observed between groups ( P=0.231) 
Bacteriology 
The rate of bacterial re-isolation is presented in Table 2. Briefly, re-isolation was considered 
positive, if bacterial swabs from liver, bone marrow or salpinx resulted in pure, fair or florid growth 
of E. coli when cultured on blood ager plates overnight. The highest re-isolation rate of E. coli from 
bone marrow (indicating septicaemia) was found in the in group 1A, in which all birds either had 
died or   were euthanized within 48 h post infection. None of the birds from the remaining groups 
tested positive from the bone marrow, and except a single bird in group 2A, these birds also 
cultured E. coli negative from the liver (Table 2), indicative of no haematogenous spread present at 
sampling. All birds in group 1A also tested positive from E. coli in the salpinx, all with 
massive/florid growth of E. coli on blood agar, and so did all birds in groups 2B. For the remaining 
groups, 3 – 6 birds per group E. coli could not be isolated by mucosal swabs from the salpinx 
(Table 2). 
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Serology 
For all samples in all experimental groups, the titre value at the day of challenge ranged from 5,000 
to 6,000 (Fig. 2A and 2B). For the groups of chickens challenged with the vaccine strain E. coli 
E44, the relative increase in antibodies against the vaccine strain was highest among birds 
vaccinated twice, followed by the group of birds vaccinated once. All chickens in group 1A (non-
autogenous vaccine; challenged with vaccine strain) were either dead or had to be euthanized 48 
hours after challenge, therefore blood had to be obtained already 48 h after challenge ( and only 
included birds that was euthanized) For this group, a four times rise in SCI07-antibodies was 
observed (Fig 2B), while rise in E. coli E44-antibodies were not detected (Fig. 2A). 
For birds challenged with E. coli E44, only birds which had been autovaccined twice had a 
significant rise in antibodies E. coli E44-antibodies after challenge (P<0.020). However, un-(auto)-
vaccined birds challenged with E.coli E44 had a significant rise of SCI07-reacting antibodies. 
For birds challenged with SCI07, birds which had been autovaccined twice had a significant rise in 
E.coli E44-reacting antibodies after challenge (P<0.014).  None of the remaining challenge groups 
had a significant rise in antibodies reacting towards either E. coli E44 or SCI07 ( In all cases 
P>0.05) 
 
For broilers, the level of MAD was not significantly different in broilers originating from 
vaccinated parents compared with broilers originating from unvaccinated parents (Fig.3), neither 
with respect to E. coli E44 antibodies (P=0.094) or E. coli E51 antibodies (P=0.3698 
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Discussion 
As with all production, cost-benefit of a given action must always be evaluated to determine if the 
action should be implemented, continued or suspended. Ascending infection due to E. coli is the 
most common infection in broiler breeders and has major impact on production economy (Jordan et 
al., 2005) Many breeder farms routinely vaccinate broiler breeder chicks with Poulvac®, and 
although the use of autogenously based E. coli vaccines is also widely implemented in industrial 
poultry production (Deb and Harry 1976; Trampel and Griffth 1997), this study is, to the authors 
knowledge, the first to evaluate the additive effects of autogenous vaccines in an experimental 
model for ascending infections. 
Judged by the clinical observations of the different experimental groups, an initial assumption of a 
protective effective of the autogenous vaccine was made, as none of the birds in the non- 
autogenously vaccinated groups survived the full experimental period when challenged with the 
vaccine strain E. coli E44 (Table 1). Rather, within 48 h after challenge all birds had either died due 
to infection or been euthanized due to animal welfare reasons. In the groups of birds which had 
been autogenously vaccinated once or twice, respectively, survival rates were significantly higher 
when challenged with the autogenous vaccine strain (Table 1). In contrast, survival rates among 
groups of birds challenged with heterologous E. coli were similar between groups independent of 
the autogenous vaccine status. These initial observations suggest that there is a protective effect of 
autogenous vaccines, at least evaluated in a seven days trial. However, birds in the groups which 
had been vaccinated twice seemed merely to have a delay in the onset of clinical disease, as these 
birds showed increasing symptoms of depression and discomfort during day 5-6 post challenge, e.g. 
progressing lack of appetite and abdominal respiration among the majority of the birds). These 
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findings were even more pronounced in the group of birds that had only been autogenously 
vaccinated once. Moreover, the clinical appearance of birds in the E. coli E44 groups on day 5 – 7 
post challenge did not differ notably between groups challenged with SCI07, leading to suggest that 
the autogenous vaccine had low protection against a homologous as well as heterologous E. coli 
challenge under these experimental conditions. Although speculative, based on the clinical 
appearance it is likely that mortality in all groups would have increased significantly after the seven 
days post infection, at which the experiment was terminated.  
Gross pathology varied markedly within each group (Fig. 1), in accordance with a previous report 
with the use of the same experimental model, indicating that host-related factors may be of major 
importance for the outcome of an ascending E. coli infection (Olsen et al., 2016). Apart from birds 
from group 1A, which all had died or had to be euthanized at 48 h, all groups had similar lesions, 
dominated by severe, fibrinopulent peritonitis, while approximately half of the birds had little 
indication of salpingitis and also tested bacteriological sterile from this organ. Only birds from 
group 1A (non-autogenously vaccinated, challenged with vaccine strain E. coli E4) sampled E. coli 
positive from the bone marrow, indicating a septicaemic condition at time of death. Whether birds 
in the other groups might also had an initial state of septicaemia but had been able to clear 
themselves within the following five days of infection, is only speculative. However, as none of 
birds in group 1B (non autogenously vaccinated, challenged with SCI07) cultured  E. coli positive 
from the bone marrow, a possible bacterial clearness cannot be assigned to the protective effect of 
the autogenous vaccine, at least not for the heterologous challenge strain. 
 
It may be argued if the infective dose was too high compared to the level of infective bacteria the 
birds would encounter under field conditions. The infective dose had be chosen based previous 
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studies (Olsen et al., 2016; Pors et al., 2014) under the assumption that this dose would be high 
enough for the birds to develop substantial pathology in the non-autogenously vaccinated control 
group, yet low enough to allow the birds to survive until the planned euthanasia seven days post 
challenge. In addition, previous studies using the same model have documented that in case the 
virulence of the strain is sufficient low, an infective dose corresponding to the dose used in the 
present study, will not result in neither clinical affection nor substantial pathology (Olsen et al., 
2016). Assuming the autogenous vaccine would have had a substantial degree of protection, it may 
be suggested that the outcome of infection in the previous study would have been considerably less 
severe, even with the use of the current infection dose of 5×105 CFU/bird. 
Serology results indicate that the vaccine stimulates an IgY antibody response, which significantly 
increased after a post vaccination challenge of the vaccine strain (Fig. 2) and being most 
pronounced in the groups autogenously vaccinated twice. However, this antibody response was not 
specifically related to a post vaccine challenge of the vaccines strain E. coli E44, as birds 
challenged with SCI_07 also had an increase of antibodies directed against the vaccine strain. 
Hence, it is more likely that strain independent antibodies against E. coli are stimulated by the 
autogenous E. coli vaccine (or the Poulvac®) vaccine, and since a whole-cell sonicate was used as 
antigen in the ELISA assay such antibodies may bind to various epitopes common to different 
strains of E. coli. Adding to the hypothesis that the antibody response is Poulvac® vaccine 
dependent is supported by the finding that the non-autogenously vaccinated chickens had higher 
rise in antibodies when challenged with SCI_07 than the autogenously vaccinated groups. The same 
increase was not observed when the non-autogenously group was challenged with E. coli E44, 
indicating that crossprotection between SCI07 and the Poulvac® strain exists, despite being of 
different sequence- and serotype. Notwithstanding that the rise in antibodies against E. coli E44 was 
significantly higher in vaccinated than non-vaccinated groups, these antibodies did not confer 
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significant protection in the present study. The lack of correlation between IgY antibodies and level 
of protection is not an uncommon observation in studies of avian bacterial infection. In fact, some 
studies have documented convincing effects of a bacterial vaccine candidate, although no rise in 
IgY antibodies could be detected (Persson and Bojesen 2015). This may likely be explained by 
another, antibody independent mode of vaccine protection, e.g. it has been suggested that Poulvac® 
induced immunity probably does not depend on the production of circulating antibodies (as 
assessed through the presence of B lymphocytes) but is linked to the presence of CD4+TCRVβ1+ 
(Fernandes et al., 2013) . This statement, however, conflicts with the finding by Sadeyen et al.( 
2015b), who showed that both Poulvac® and an inactivated culture of the same strain as included in 
the Poulvac® vaccine (APEC O78) stimulated a cell-mediated as well as a pronounced humoral 
response in an intra-airsac model of acute colibacilliosis in turkey poults. Yet, another study 
demonstrated that a protective effect of Poulvac® vaccines strictly requires a cyclophosphamide-
sensitive cell population that includes B cells (Sadeyen et al., 2015a). 
For a vaccine aiming to protect broilers through vertical transfer of antibodies, high levels of 
circulating antibodies are crucial. In the present study, the transferability of the antibodies may also 
be questioned, as day-old broilers of vaccinated parents did not differ in antibody titres from day-
old offspring of un-vaccinated broiler breeders (Fig. 3).  
In conclusion, vaccination with an autogenous vaccine seemed to stimulate an IgY antibody 
response when birds were challenged with a homologous strain, but only if the birds had been 
autogenously vaccinated twice. Based on pathology the autogenously vaccine did not confer 
protection against neither a homologue nor a heterologous challenge strain in the applied 
experimental model. Nevertheless, the autogenous vaccine seemed to postpone the clinical onset of 
infection, and mortality of birds was lowest in the group of birds vaccinated twice, followed by the 
group of birds vaccine once, whereas a 100 % mortality of non- autogenously vaccinated group 
 
 
16 
 
challenged with the autovaccine strain was observed. Finally, as all birds in all groups had initially 
been vaccinated with Poulvac®, protection against ascending infections of the two challenge strains 
in the experiment model could not be documented.  
To verify the observed lack of protection against ascending E. coli infections provided by 
Poulvac®, an autogenous vaccine, or a combination hereof, future experimental studies should 
include dose titration, as protection against lower infection doses may be possible. 
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Figure legends  
Figure 1. Scatter plot of cumulative lesion scores for experimental trials with a vaccine strain of E. 
coli (E. coli  E44) and a vaccine-unrelated strain of E. coli ( SCI_07) evaluated in an avian model 
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for infection of oviduct in three different groups of broiler breeders. Maximum lesion score are: 
Total lesions: 38 (panel A), peritoneum: 15 (B), ovary: 9 (C), and salpinx: 9 (D). Each point 
represents one chicken within the group. Green circles: Unvaccinated chickens challenged with the 
vaccine strain E. coli E. 44; Red circles:  Unvaccinated chickens challenged with the vaccine strain 
E. coli SCI_07; Green triangles: 1x autogenously vaccinated chickens challenged with the vaccine 
strain E. coli E. 44; Red triangles: 1x autogenously vaccinated chickens challenged with SCI_07; 
Green squares 2x autogenously vaccinated chickens challenged with the vaccine strain E. coli E. 44; 
Green squares 2x autogenously vaccinated chickens challenged with SCI_07. The asterisks indicate 
statistical significance: * P<0.05; **P<0.01; ***P<0.0001 
 
Figure 2. IgY souble antibodies against E. coli E44 (A), and E. coli SCI_07 (B) in broiler breeders 
challenged with either E. coli E44 or SCI_07. Blue bars: Before Challenge; The right adjacent bar: 
Green: after challenge with E. coli E44, Red: after challenge with SCI_07.  Au: autogenously 
vaccinated. The asterisks indicate statistical significance: * P<0.05 
 
Figure 3.  IgY soluble antibodies in offspring from broiler breeders vaccinated with an 
autogenously vaccine including two strains of E. coli, E. coli E44 and E. coli E51, compared to 
offspring originating from unvaccinated breeders. No significant differences were observed 
between the level of antibodies originating from unvaccinated versus vaccinated parents for any of 
the two E. coli strains ( P=0.3407) 
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Table 1. Overview of experimental groups.  Each group consisted of 2x10 broiler breeders (age 28 weeks) 
1 All chickens received a dose of 5x105 CFU/mL of the challenge strain. a  Survival rates were significantly 
lower than for any of the other groups (P<0.0001) 
 
 
Group E. coli autogenous 
vaccine (week of age) 
Challenge strain1 Average 
weight at day 
of challenge 
Survived the full 
experimental period (7 
days post challenge) 
1A 
1B 
None E. coli E44 3699 0/10 a 
None SCI_07 3669 10/10 
2A 1 time (18) E. coli E44 3532 8/10 
2B 1 time (18) SCI_07 3529 10/10 
3A 2 times (14 and 18) E. coli E44 3563 9/10 
3B 2 times (14 and 18) SCI_07 3543 10/10 
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Table 2.  Semi-quantitative estimation of bacteria per swab obtained from liver, salpinx and bonemarrow  of 
each chicken. Each group contained 10 chickens 
1 Growth was considered poor if less than 10 colonies of E. coli were present on the agar plate after 24h incubation. 
 
 
Group  Challenge 
strain 
Growth of Escherichia coli on blood agar plates after 24h incubation at 37° C 
                    Liver                  Bone marrow                        Salpinx  
  Sterile/ 
Poor 
growth1  
Fair 
growth 
Massive 
growth 
Sterile/Poor 
growth  
Fair 
growth 
Massive 
growth 
Sterile/Poor 
growth  
Fair 
grow
th 
Massive 
growth 
1A E.coli E44  0 2 8 2 2 6 0 0 10 
1B SCI_07 
10 0 0 10 0 0 6 2 2 
2A E.coli E44 
9 0 1 10 0 0 3 2 5 
2B SCI_07 
10 0 0 10 0 0 0 3 7 
3A E.coli E44 
10 0 0 10 0 0 4 5 2 
3B SCI_07 
9 0 0 10 0 0 4 1 5 
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Table 3. Overview of mean (median) lesion scores. Scoring was done according to Pors et al. (2014). 
Maximum score (achieved at highly severe macroscopic pathology) is stated under each category, 0 is given 
to birds presented with no macroscopically lesions. In addition, the spleen is scored for proliferation and 
lymphatic reaction (not shown in the table). 
 
 
 
Group Challenge strain Peritoneum 
[0-15] 
Ovaries 
[0-9] 
Salpinx 
[0-9] 
Total 
[0-38] 
      
1A E. coli E44  12 
(11) 
5,5 
(6) 
5,2 
(5) 
24 
(25) 
1B SCI_07 8,6 
(12,5) 
3,3 
(3) 
2,7 
(2) 
16,9 
(17,5) 
2A E. coli E44 11,1 
(14) 
 
3,5 
(3) 
1.8 
(2) 
18,5 
(20) 
2B SCI_07 13 
(14) 
4,2 
(4,5) 
1,9 
(4) 
22,2 
(23,5) 
 
3A E. coli E44 11,6 
(13) 
4 
(4) 
1,3 
(1) 
19,3 
(20) 
3B SCI_07 10,5 
(10.5) 
3,4 
(3.5) 
1,6 
(1) 
17,1 
(17) 
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